Answers are grounded in this paper and cite their sources.
Bromelain-digested casein peptide pool (BDCPP) has been shown to alleviate chronic stress-induced behavioral and neurobiological alterations in rats; however, the molecular basis of these effects remains unclear. In the present study, an integrated in silico approach was used to investigate the possible neuroprotective mechanisms of BDCPP. Peptides generated following simulated bromelain digestion of casein were screened for safety, gastrointestinal stability, physicochemical properties, and predicted neuroprotective activities. We identified 11 peptides with favorable characteristics and selected two representative peptides (β-casein-P2 and κ-casein-P19 ) for molecular docking and molecular dynamics analyses. Both peptides showed strong and stable interactions with dipeptidyl peptidase-4 (DPP4) and glutamate carboxypeptidase II (GCPII), proteins involved in gut–brain axis communication, neuroinflammation, and glutamatergic signaling. Molecular dynamics simulations suggested the stability of the selected peptide–receptor complexes throughout the simulation period. Importantly, several peptides within the BDCPP pool displayed similar predicted biological activities, suggesting that the observed effects of BDCPP are likely mediated by the collective action of multiple bioactive peptides rather than a single dominant component. The identified interactions with DPP4 and GCPII may provide a potential molecular basis for the previously reported behavioral, cognitive, and neurobiological benefits of BDCPP and support its potential as a food-derived neuroprotective ingredient. However, these computational predictions should be considered as a hypothesis-generating framework and require further experimental validation.
No takes yet. Share an insight, caveat, or question.
Yarijani et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: